Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$118M Sell
917,223
-129,892
-12% -$15.2M 0.14% 148
2026
Q1
$126M Buy
+1,047,115
New +$121M 0.17% 133
2025
Q3
$29M Buy
+345,081
New +$28.4M 0.16% 99

Other funds holding MRK

CIBC Bancorp USA's MRK Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Merck (MRK) stake by 12% in Q2 2026, selling an estimated $15.2M and leaving 917,223 shares worth $118M. The position accounts for 0.14% of the portfolio, ranked #148.

CIBC Bancorp USA first reported a position in MRK in Q3 2025 and has held it in 3 quarters since. The position peaked at $126M in Q1 2026. 3,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • CIBC Bancorp USA held 917,223 shares of Merck worth $118M as of Q2 2026.
  • CIBC Bancorp USA sold 129,892 Merck shares in Q2 2026, an estimated $15.2M.
  • Merck made up 0.14% of CIBC Bancorp USA's portfolio in Q2 2026, its #148 holding.
  • CIBC Bancorp USA first reported a position in Merck in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Merck position peaked at $126M in Q1 2026.
  • 3,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.